Found 106 matching trials
Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis PHASE4 This study will examine the safety, tolerability, and antiviral efficacy of...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study PHASE2 The primary objective of this study is to evaluate the efficacy, safety and...
Show More Location
Multiple Locations
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection PHASE3 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection PHASE3 This study will assess the efficacy, safety, and tolerability of 16 or 24 w...
Show More Location
Multiple Locations
Learn More & Join Trial
Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection PHASE2 This study is to evaluate the safety, tolerability, and antiviral activity ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection PHASE2 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Learn More & Join Trial
Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083) PHASE2 This is a randomized, multi-site, open-label trial of the co-administration...
Show More Location
Multiple Locations
Learn More & Join Trial
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF PHASE2 People who are infected with Hepatitis C Virus (HCV) have a great chance of...
Show More Location
Ucsf Aids Crs (801)
Learn More & Join Trial
Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant PHASE2 This study will evaluate ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combina...
Show More Location
Multiple Locations
Learn More & Join Trial